title: Adjuvant therapeutic effects of galantamine on apathy in a schizophrenia patient.
authors.forename: David S
authors.initials: DS
authors.lastname: Arnold
authors.forename: Richard B
authors.initials: RB
authors.lastname: Rosse
authors.forename: Dwight
authors.initials: D
authors.lastname: Dickinson
authors.forename: Rhonda
authors.initials: R
authors.lastname: Benham
authors.forename: Stephen I
authors.initials: SI
authors.lastname: Deutsch
authors.forename: Matthew W
authors.initials: MW
authors.lastname: Nelson
mesh_terms: D000328:Adult; D000342:Affective Symptoms / Q000188:drug therapy* / Q000523:psychology; D002800:Cholinesterase Inhibitors / Q000494:pharmacology / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D005702:Galantamine / Q000494:pharmacology / Q000627:therapeutic use*; D006760:Hospitalization; D006801:Humans; D008297:Male; D008875:Middle Aged; D011619:Psychotropic Drugs / Q000627:therapeutic use; D011978:Receptors, Nicotinic / Q000187:drug effects; D012559:Schizophrenia / Q000188:drug therapy*; D012565:Schizophrenic Psychology; D016896:Treatment Outcome
chemical_list: D002800:Cholinesterase Inhibitors; D011619:Psychotropic Drugs; D011978:Receptors, Nicotinic; D005702:Galantamine